About EPIC

Study Resources

Vital status and cancer end-points

Follow-up aimed at identifying cancer cases occurring among the EPIC cohort is based on population cancer registries in seven of the participating countries (Denmark, Italy, the Netherlands, Norway, Spain, Sweden, and the United Kingdom) and on a combination of methods including health insurance records, cancer and pathology registries, and active follow-up through study participants and their next of kin in three countries (France, Germany, and Greece). A working group created in 1996 (End-Point Committee) prepared a detailed protocol for the collection and standardization of clinical and pathological data on each cancer site. In parallel, data on total and cause-specific mortality are collected at the EPIC study centres through mortality registries or active follow-up and death-record collection.